| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/08/2009 | US7585835 GASP1: a follistatin domain containing protein |
| 09/08/2009 | US7585676 Retroviral vector |
| 09/08/2009 | US7585673 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner |
| 09/08/2009 | US7585671 Hedgehog interacting proteins and uses related thereto |
| 09/08/2009 | US7585666 genetically engineered chimeras comprising ligand binding domain fused to an effector domain of an apoptosis signaling molecule and second encoding a cis acting regulatory element; for use in/ex vivo |
| 09/08/2009 | US7585659 Carotene synthase gene and uses therefor |
| 09/08/2009 | US7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
| 09/08/2009 | US7585519 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 09/08/2009 | US7585498 Recombinant Adenoviruses which function as helper viruses to gutted Ad viruses lacking viral coding sequences; gene therapy |
| 09/08/2009 | CA2478066C Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 09/08/2009 | CA2281955C Ikb kinase, subunits thereof, and methods of using same |
| 09/03/2009 | WO2009108931A2 Method of treating cancer |
| 09/03/2009 | WO2009108856A2 Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof |
| 09/03/2009 | WO2009108706A2 Methods for inhibiting six 1 and eya proteins |
| 09/03/2009 | WO2009108690A1 Composition comprising sirna-polycation complex for iontophoresis |
| 09/03/2009 | WO2009108340A2 Leptin agonist and methods of use |
| 09/03/2009 | WO2009108217A2 Compositions comprising k-ras sirna and methods of use |
| 09/03/2009 | WO2009106767A2 Use of a homeoprotein of the bicoid family for preventing or treating retinal ganglionic neurone degeneration |
| 09/03/2009 | WO2009106713A2 New class of cationic lipids for transporting active agents into cells |
| 09/03/2009 | WO2009016507A3 Method for manufacturing linear polyethylenimine (pei) for transfection purpose and linear pei obtained with such method |
| 09/03/2009 | WO2008095033A8 Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| 09/03/2009 | US20090221807 2' Deoxy-2'-Alkylnucleotide Containing Nucleic Acid |
| 09/03/2009 | US20090221686 Modulation of the Transcription of Pro-Inflammatory Gene Products |
| 09/03/2009 | US20090221684 Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof |
| 09/03/2009 | US20090221681 Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer |
| 09/03/2009 | US20090221678 target heat shock protein (hsp) 27 in vivo; antisense oligonucleotide or RNAi nucleotide inhibitor with sequence specificity for hsp27 mRNA; injectable dosage unit form |
| 09/03/2009 | US20090221677 Methods for Reducing Body Fat and Increasing Lean Body Mass by Reducing Stearoyl-COA Desaturase 1 Activity |
| 09/03/2009 | US20090221673 Compositions and Methods for Regulating RNA Translation via CD154 CA-Dinucleotide Repeat |
| 09/03/2009 | US20090221670 Method for diagnosis and treatment of a mental disease |
| 09/03/2009 | US20090221492 Expression of active human factor ix in mammary tissue of transgenic animals |
| 09/03/2009 | US20090221474 Histone deacetylases, and uses related thereto |
| 09/03/2009 | US20090220967 Systemic Carnitine Deficiency Gene and Uses Thereof |
| 09/03/2009 | US20090220569 Prevascularized Constructs for Implantation to Provide Blood Perfusion |
| 09/03/2009 | US20090220505 Methods of inhibiting amyloid toxicity |
| 09/03/2009 | US20090220498 Method for Discovering Inhibitors of the Epstein-Barr Virus-Induced Gene 3 (EBI3) and Derivatives Thereof for the Treatment of Metastasizing Tumors and Allergic Asthma |
| 09/03/2009 | US20090220460 Virus strains |
| 09/03/2009 | US20090220458 Pseudotyped retroviral vectors and methods of use thereof |
| 09/03/2009 | CA2717026A1 Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof |
| 09/03/2009 | CA2711866A1 Use of a homeoprotein of the bicoid family for preventing or treating retinal ganglionic neurone degeneration |
| 09/03/2009 | CA2708988A1 New class of cationic lipids for transporting active agents into cells |
| 09/03/2009 | CA2704737A1 Compositions comprising k-ras sirna and methods of use |
| 09/02/2009 | EP2094847A2 Inhibition of gpr4 |
| 09/02/2009 | EP2094301A1 Poxviridae treatment comprising tap-1 and/or tap-2 as a molecular adjuvant |
| 09/02/2009 | EP1601325B1 Antisense oligonucleotides that inhibit expression of hif-1 |
| 09/02/2009 | EP1392349B1 Use of angiotensinogen and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/02/2009 | EP1005368B1 Use of nucleic acids containing unmethylated CpG dinucleotide in combination with alum as adjuvants |
| 09/02/2009 | CN101522222A Identification of a micro-RNA that activates expression of beta-myosin heavy chain |
| 09/02/2009 | CN101518655A Application of human interleukin-24 gene recombined vector mediated by adenovirus in preparing tumor analgesic medicament |
| 09/02/2009 | CN101518644A Application of Ang-2 and genes thereof in pharmacy |
| 09/02/2009 | CN101518483A Biological vision assisting system |
| 09/02/2009 | CN100534436C Polynucleotide therapy |
| 09/01/2009 | US7582732 Lymphocyte antigen 6 complex, locus H (LY6H) protein for use in treatment and prevention of neurodegenerative diseases |
| 09/01/2009 | US7582619 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 09/01/2009 | US7582613 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 09/01/2009 | US7582602 Hirulog-like peptide and gene therapy |
| 09/01/2009 | US7582478 Cleaved serum response factor in cardiac diagnosis and therapy |
| 09/01/2009 | US7582451 Carotene synthase gene and uses therefor |
| 09/01/2009 | US7582448 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
| 09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
| 09/01/2009 | US7582430 Immunoliposome-nucleic acid amplification (ILNAA) assay |
| 09/01/2009 | US7582425 Identifying subjects who have or are at risk for developing Hereditary Spastic Paraplegia by detecting the presence or absence of one or more variations in the atlastin gene or treating HSP by administering atlastin |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | US7582290 Use in suicide gene therapy of cancer cells and producing immunotoxins; infecting the cell with an adenovirus produced by a packaging cell line, where an adenoviral vector of a promoter is linked to a nucleic acid encoding the A subunit of diphtheria toxin A or Pseudomonas Exotoxin A, mutated EF-2 gene |
| 09/01/2009 | US7582288 Methods of targeting multiple cytokines |
| 09/01/2009 | CA2327434C Dna immunization against chlamydia infection |
| 09/01/2009 | CA2283536C Compositions and methods for elimination of unwanted cells |
| 09/01/2009 | CA2213343C Chimeric adenoviral fiber protein and methods of using same |
| 08/27/2009 | WO2009105759A2 Micro-rnas that modulate smooth muscle proliferation and differentiation and uses thereof |
| 08/27/2009 | WO2009105690A2 Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea |
| 08/27/2009 | WO2009105669A2 Angiogenesis inhibition |
| 08/27/2009 | WO2009105355A2 A novel neospora caninum vaccine |
| 08/27/2009 | WO2009105260A2 Ultra-small rnas as toll-like receptor-3 antagonists |
| 08/27/2009 | WO2009105135A1 Compositions for enhanced uptake of viral vectors in the myocardium |
| 08/27/2009 | WO2009104896A2 Nucleic-acid pharmaceutical composition for cancer therapy |
| 08/27/2009 | WO2009104889A2 Trem-2 gene and protein as inhibitors of expression of ga733-2, transgenic animals comprising the same, and uses thereof |
| 08/27/2009 | WO2009104794A1 Method for producing founder animal for reproducing animals having lethal phenotype caused by gene modification |
| 08/27/2009 | WO2009104649A1 Synthetic glycolipid-containing liposomes |
| 08/27/2009 | WO2009104388A1 Prophylactic/therapeutic agent for collagenosis |
| 08/27/2009 | WO2009104051A2 Combinational therapeutics for treatment of prostate cancer using epoxy encapsulated magnetic particles and rnai medicine |
| 08/27/2009 | WO2009073941A3 Ternary liposomal composition containing a polynucleotide |
| 08/27/2009 | WO2008141151A3 Synthetic herpes simplex viruses type-1 for treatment of cancers |
| 08/27/2009 | US20090217403 Means and methods for generating a t cell against an antigen of interest |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215871 Simian adenovirus vectors and methods of use |
| 08/27/2009 | US20090215870 Compositions and methods for targeting of viral vectors |
| 08/27/2009 | US20090215868 Therapeutic Medicament for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Pulmonary Hypertension |
| 08/27/2009 | US20090215691 NOGO Receptor Antagonists |
| 08/27/2009 | US20090215167 Cationic graft-copolymer for non-viral gene delivery vector |
| 08/27/2009 | US20090215164 Recombinant gene of adenovirus vector and p53 gene for treating proliferative diseases |
| 08/27/2009 | US20090215089 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 08/27/2009 | US20090215065 Diagnosis and treatment of Hereditary Spastic Paraplegia |
| 08/27/2009 | US20090214639 Omp p6 vaccine for treating and preventing chlamydia infection |
| 08/27/2009 | US20090214630 Compositions and Methods for the Treatment of Inflammatory Bowel Disease Utilizing NF-KappaB Decoy Polynucleotides |
| 08/27/2009 | US20090214589 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 08/27/2009 | US20090214575 Annexin II and uses thereof |
| 08/27/2009 | US20090214505 For treating an excess of a substrate for a hyaluronidase, such as reducing scar tissue |
| 08/27/2009 | US20090214493 Cardiac Muscle Regeneration Using Mesenchymal Stem Cells |
| 08/27/2009 | US20090214492 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 08/27/2009 | US20090214477 Human Marker Genes and Agents for Diagnosis, Treatment and Prophylaxis of Cardiovascular Disorders and Artherosclerosis |
| 08/27/2009 | CA2716343A1 Micro-rnas that modulate smooth muscle proliferation and differentiation and uses thereof |